The older group showed a trend toward a higher rate of 5-year overall survival among elderly patients with EGFR mutations (100%) than among those with wild-type EGFR (66.2%), but the difference was not significant.
← all excerpts
Clinicopathological features and EGFR gene mutation status in elderly patients with resected non-small-cell lung cancer.
1
—
—